News

Discover all the latest news from Bioprojet: events, updates, innovations… Stay informed about the latest scientific advances and new developments in our therapeutic areas.

#BIONEWS

Sep 2024

Bioprojet participates in the 27th edition of the Sleep Europe Congress

Bioprojet will be present from 25th to 27th September 2024 for the 27th edition of the Sleep Europe Congress organised by European Sleep Research Society (ESRS) in Seville, Spain. The congress will bring together clinicians, researchers, scientists and students to discuss the latest advances in sleep medicine and research. Meet our team on the Bioprojet […]

READ

Juil 2024

Bioprojet will be present at the European Narcolepsy Network (EUNN) Congress

Bioprojet will be present from 5th to 6th July 2024 at the European Narcolepsy Network (EUNN) Congress, in collaboration with European Sleep Foundation – ESF, to be held in Montpellier (France). The congress brings together patients and professionals for clinical and scientific sessions on narcolepsy and its treatments, including conferences, research presentations, and discussions on […]

READ

Jui
2024
Jui
2024
Bioprojet will be present at the 9th edition of the Bastide Médical Conference

Bioprojet will be present at the 9th edition of the Bastide Médical Conference

Bioprojet will be attending the 9th edition of the Bastide Médical Conference, held from June 14 to 15, 2024, in Barcelona. This event is a must-attend for respiratory care experts. Each year, around 350 healthcare professionals gather for two days to participate in conferences, discussions, and debates focused on the latest scientific advancements and innovations […]

READ

Avr
2024
Avr
2024
Acquisition by Bioprojet of a new molecule for the treatment of narcolepsy

Acquisition by Bioprojet of a new molecule for the treatment of narcolepsy

Breaking News ! We are delighted to announce an exclusive and worldwide acquisition by Bioprojet, in partnership with Harmony Biosciences, of a new molecule for the treatment of narcolepsy and other sleep/wake disorders. TPM-1116 is a new highly potent and selective oral orexin-2 receptor (OX2R) agonist discovered by Teijin Pharma Limited, a Japanese pharmaceutical group. […]

READ

Sep
2023
Sep
2023
Bioprojet participate in GERDA course in Rouen

Bioprojet participate in GERDA course in Rouen

On September 28 and 29, the GERDA course will take place in Rouen. This 44th course will once again be an opportunity to discuss and continue to progress together in the exciting field of dermato-allergology. For more information : https://www.gerda2023.com/

READ

Sep
2023
Sep
2023
Bioprojet takes part in the 7th Garlaban Pediatric Day

Bioprojet takes part in the 7th Garlaban Pediatric Day

On Saturday September 16, the 7th Garlaban Pediatric Day will take place. See you in Aubagne.

READ

PAGE 2 SUR 5